Common name
bromobenzene
IUPAC name
bromobenzene
SMILES
Brc1ccccc1
Common name
bromobenzene
IUPAC name
bromobenzene
SMILES
Brc1ccccc1
INCHI
InChI=1S/C6H5Br/c7-6-4-2-1-3-5-6/h1-5H
FORMULA
C6H5Br
Common name
bromobenzene
IUPAC name
bromobenzene
Molecular weight
157.008
clogP
2.655
clogS
-2.478
Frequency
0.0045
HBond Acceptor
0
HBond Donor
0
Total PolarSurface Area
0
Number of Rings
1
Rotatable Bond
0
| Drug ID | Common name | Structure CAS | Compound class | Therapeutic area |
|---|---|---|---|---|
| FDBD00285 | Dexbrompheniramine |
|
Histamine H1 Antagonists; Histamine Antagonists; Respiratory System; Antihistamines for Systemic Use; Substituted Alkylamines; | For treatment and relief of symptoms of allergies, hay fever, and colds. |
| FDBD00288 | Remoxipride |
|
Antipsychotic Agents; Dopamine Antagonists; Nervous System; Psycholeptics; Benzamides; CYP2D6 Inducers; CYP2D6 Inducers (strong); | Remoxipride is an atypical antipsychotic once used for the treatment of schizophrenia. |
| FDBD00697 | Brompheniramine |
|
Anti-Allergic Agents; Histamine H1 Antagonists; Respiratory System; Antihistamines for Systemic Use; Substituted Alkylamines; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP2C8 Inhibitors; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; Cytochrome P-450 CYP2C8 Inducers; Cytochrome P-450 CYP2B6 Inducers; Cytochrome P-450 CYP2B6 Inhibitors; CYP2B6 Inhibitors (strong); CYP2D6 Inducers; CYP2D6 Inducers (strong); CYP2E1 Inhibitors; CYP2E1 Inducers; CYP2E1 Inducers (strong); CYP3A4 Inhibitors; | For the treatment of the symptoms of the common cold and allergic rhinitis, such as runny nose, itchy eyes, watery eyes, and sneezing. |
| FDBD00818 | Bromfenac |
|
Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Ophthalmologicals; Sensory Organs; | For the treatment of postoperative inflammation in patients who have undergone cataract extraction. |
| FDBD01005 | Bretylium |
|
Antihypertensive Agents; Anti-Arrhythmia Agents; Adrenergic Antagonists; | For use in the prophylaxis and therapy of ventricular fibrillation. Also used in the treatment of life-threatening ventricular arrhythmias, such as ventricular tachycardia, that have failed to respond to adequate doses of a first-line antiarrhythmic agent, such as lidocaine. |
| FDBD01081 | Bromodiphenhydramine |
|
Histamine Antagonists; Respiratory System; Aminoalkyl Ethers; Antihistamines for Systemic Use; | For management of symptoms related to hay fever and other types of allergy and used to help bring up phlegm, thin secretions, and make a cough productive. |
| FDBD01582 | MACITENTAN |
|
Antihypertensive Agents; Vasodilator Agents; Cardiovascular System; Antihypertensives for Pulmonary Arterial Hypertension; Cytochrome P-450 CYP2C19 Inducers; CYP3A4 Inhibitors; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; | Macitentan is indicated for patients with pulmonary arterial hypertension. |
| FDBD01672 | Pinaverium |
|
Alimentary Tract and Metabolism; Drugs for Functional Gastrointestinal Disorders; | |
| FDBD01913 | broflanilide |
|
Insecticide | Insecticide |
| FDBD02035 | bromo-DDT |
|
Insecticide | Insecticide |
13 ,
2
| FRAGNAME | PDBID | SIMILIRITY | XSCORE | SMILE | HAC |
|---|---|---|---|---|---|
| 1w6j_ligand_frag_0.mol2 | 1w6j | 1 | -7.05 | c1ccc(Br)cc1 | 7 |
| 4xt2_ligand_frag_2.mol2 | 4xt2 | 1 | -7.01 | c1cc(Br)ccc1 | 7 |
| 5afj_ligand_frag_1.mol2 | 5afj | 1 | -7.00 | c1ccc(Br)cc1 | 7 |
| 1std_ligand_frag_3.mol2 | 1std | 1 | -6.96 | c1ccc(cc1)Br | 7 |
| 6std_ligand_frag_0.mol2 | 6std | 1 | -6.96 | c1(Br)ccccc1 | 7 |
| 4d1c_ligand_frag_2.mol2 | 4d1c | 1 | -6.94 | c1cccc(c1)Br | 7 |
| 4std_ligand_frag_3.mol2 | 4std | 1 | -6.94 | c1ccc(cc1)Br | 7 |
| 1h3c_ligand_frag_11.mol2 | 1h3c | 1 | -6.92 | c1ccc(cc1)Br | 7 |
| 4g1f_ligand_frag_2.mol2 | 4g1f | 1 | -6.92 | c1ccccc1Br | 7 |
107 ,
11
